Dr Cedric Tremblay completed his PhD in Cellular and Molecular Biology (Medicine) through the Laval University, in Quebec City, Canada in 2008. His PhD studies at the CHUL Research Center, under the supervision of Prof. Madeleine Carreau and Georges Levesque, focused on the role of signaling pathways in the development of bone marrow failure disorders using mouse models of Fanconi anemia. Dr Tremblay then pursued post-doctoral studies in the laboratory of Dr Trang Hoang at the IRIC – University of Montreal from 2008 to 2011, to examine the mechanism of collaboration between the oncogenes SCL/TAL1, LMO1 and Notch1 during leukemia development. In 2011, Dr Tremblay relocated to the Australian Centre for Blood Diseases (ACBD), Monash University in the Stem Cell Research Group of Associate Professor David Curtis to investigate the molecular mechanisms involved in leukemia progression. In 2014, Dr Tremblay was appointed as a research fellow at the ACBD and awarded a research Grant-in Aid from the Leukaemia Foundation of Australia to establish a research program focused on the role of signalling pathways in treatment-resistance and relapse.